Literature DB >> 32310290

Evaluation of Medical Surveillance and Incidence of Post-September 11, 2001, Thyroid Cancer in World Trade Center-Exposed Firefighters and Emergency Medical Service Workers.

Hilary L Colbeth1,2, Natalia Genere3, Charles B Hall4,5, Nadia Jaber1, Juan P Brito3,6, Omar M El Kawkgi3,6, David G Goldfarb1,2, Mayris P Webber1,4,7, Theresa M Schwartz1,2, David J Prezant1,8, Rachel Zeig-Owens1,2,4.   

Abstract

Importance: Elevated incidence rates of thyroid cancer among World Trade Center (WTC)-exposed individuals may be associated with the identification of asymptomatic cancers during medical surveillance. Objective: To examine the association between WTC exposure and thyroid cancer among Fire Department of the City of New York (hereafter, Fire Department) rescue/recovery workers as well as the association with medical surveillance. Design, Setting, and Participants: This closed-cohort study classified the method of detection (asymptomatic and symptomatic) of thyroid cancers in 14 987 men monitored through the Fire Department-WTC Health Program diagnosed from September 12, 2001, to December 31, 2018. Age-, sex-, and histologic-specific Fire Department incidence rates were calculated and compared with demographically similar men in Olmsted County, Minnesota, from the Rochester Epidemiology Project using age-standardized rates, relative rates (RRs), and 95% CIs. The secondary analysis was restricted to papillary carcinomas. Exposures: World Trade Center exposure was defined as rescue/recovery work at the WTC site from September 11, 2001, to July 25, 2002. Main Outcomes and Measures: The outcomes evaluated comprised (1) number of incident thyroid cancers and their detection method categorizations in the Fire Department and Rochester Epidemiology Project cohorts; (2) Fire Department, Rochester Epidemiology Project, and Surveillance, Epidemiology, and End Results-21 age-standardized incidence rates of thyroid cancer; and (3) RRs comparing Fire Department and Rochester Epidemiology Project overall and by detection method categorization.
Results: Seventy-two post-9/11 Fire Department cases of thyroid cancer were identified. Among the 65 cases (90.3%) with a categorized detection method, 53 cases (81.5%) were asymptomatic and 12 cases (18.5%) were symptomatic. Median (interquartile range) age at diagnosis was 50.2 (44.0-58.6) vs 46.6 (43.9-52.9) years for asymptomatic vs symptomatic cases. Associated primarily with asymptomatic cancers, the overall age-standardized incidence of Fire Department thyroid cancers (24.7; 95% CI, 17.4-52.3) was significantly higher than the Rochester Epidemiology Project (10.4; 95% CI, 8.5-12.7) and Surveillance, Epidemiology, and End Results-21 (9.1; 95% CI, 9.0-9.1) per 100 000 person-years. Furthermore, the RR of thyroid cancer among symptomatic men in Fire Department cases was not significantly different from that of men in the Rochester Epidemiology Project (0.8; 95% CI, 0.4-1.5); however, the rate of asymptomatic cancers was more than 3-fold that of the Rochester Epidemiology Project rate (RR, 3.1; 95% CI, 2.1-4.7). Conclusions and Relevance: Excess asymptomatic thyroid cancer in Fire Department WTC-exposed rescue/recovery workers is apparently attributable to the identification of occult lesions during medical surveillance. Among WTC-exposed cohorts and the general population, these findings appear to have important implications for how thyroid cancer incidence rates are interpreted and how diagnoses should be managed.

Entities:  

Mesh:

Year:  2020        PMID: 32310290      PMCID: PMC7171583          DOI: 10.1001/jamainternmed.2020.0950

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  47 in total

1.  Cough and bronchial responsiveness in firefighters at the World Trade Center site.

Authors:  David J Prezant; Michael Weiden; Gisela I Banauch; Georgeann McGuinness; William N Rom; Thomas K Aldrich; Kerry J Kelly
Journal:  N Engl J Med       Date:  2002-09-09       Impact factor: 91.245

2.  Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.

Authors:  Briseis Aschebrook-Kilfoy; Mary H Ward; Mona M Sabra; Susan S Devesa
Journal:  Thyroid       Date:  2010-12-27       Impact factor: 6.568

3.  Increasing incidence of thyroid cancer in the United States, 1973-2002.

Authors:  Louise Davies; H Gilbert Welch
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

Review 4.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

Review 5.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

6.  The Impact of Subclinical Disease and Mechanism of Detection on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Olmsted County, Minnesota During 1935 Through 2012.

Authors:  Juan P Brito; Alaa Al Nofal; Victor M Montori; Ian D Hay; John C Morris
Journal:  Thyroid       Date:  2015-07-30       Impact factor: 6.568

7.  Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.

Authors:  Briseis A Kilfoy; Susan S Devesa; Mary H Ward; Yawei Zhang; Philip S Rosenberg; Theodore R Holford; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

8.  The clinical and economic burden of a sustained increase in thyroid cancer incidence.

Authors:  Briseis Aschebrook-Kilfoy; Rebecca B Schechter; Ya-Chen Tina Shih; Edwin L Kaplan; Brian C-H Chiu; Peter Angelos; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-15       Impact factor: 4.254

9.  Molecular Study of Thyroid Cancer in World Trade Center Responders.

Authors:  Maaike A G van Gerwen; Stephanie Tuminello; Gregory J Riggins; Thais B Mendes; Michael Donovan; Emma K T Benn; Eric Genden; Janete M Cerutti; Emanuela Taioli
Journal:  Int J Environ Res Public Health       Date:  2019-05-07       Impact factor: 3.390

10.  Cancer incidence in world trade center rescue and recovery workers, 2001-2008.

Authors:  Samara Solan; Sylvan Wallenstein; Moshe Shapiro; Susan L Teitelbaum; Lori Stevenson; Anne Kochman; Julia Kaplan; Cornelia Dellenbaugh; Amy Kahn; F Noah Biro; Michael Crane; Laura Crowley; Janice Gabrilove; Lou Gonsalves; Denise Harrison; Robin Herbert; Benjamin Luft; Steven B Markowitz; Jacqueline Moline; Xiaoling Niu; Henry Sacks; Gauri Shukla; Iris Udasin; Roberto G Lucchini; Paolo Boffetta; Philip J Landrigan
Journal:  Environ Health Perspect       Date:  2013-04-23       Impact factor: 9.031

View more
  7 in total

1.  Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy.

Authors:  L Dal Maso; C Panato; A De Paoli; V Mattioli; D Serraino; R Elisei; G Zoppini; C Gobitti; E Borsatti; E Di Felice; F Falcini; S Ferretti; S Francisci; P Giorgi Rossi; S Guzzinati; G Mazzoleni; D Pierannunzio; S Piffer; S Vaccarella; M Vicentini; M Zorzi; S Franceschi; U Fedeli
Journal:  J Endocrinol Invest       Date:  2021-01-18       Impact factor: 4.256

Review 2.  World Trade Center Health Program: First Decade of Research.

Authors:  Albeliz Santiago-Colón; Robert Daniels; Dori Reissman; Kristi Anderson; Geoffrey Calvert; Alexis Caplan; Tania Carreón; Alan Katruska; Travis Kubale; Ruiling Liu; Rhonda Nembhard; W Allen Robison; James Yiin; John Howard
Journal:  Int J Environ Res Public Health       Date:  2020-10-06       Impact factor: 3.390

3.  Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up.

Authors:  Jiehui Li; Janette Yung; Baozhen Qiao; Erin Takemoto; David G Goldfarb; Rachel Zeig-Owens; James E Cone; Robert M Brackbill; Mark R Farfel; Amy R Kahn; Maria J Schymura; Moshe Z Shapiro; Christopher R Dasaro; Andrew C Todd; Dana Kristjansson; David J Prezant; Paolo Boffetta; Charles B Hall
Journal:  J Natl Cancer Inst       Date:  2022-02-07       Impact factor: 13.506

4.  Cancer incidence in World Trade Center-exposed and non-exposed male firefighters, as compared with the US adult male population: 2001-2016.

Authors:  Mayris P Webber; Ankura Singh; Rachel Zeig-Owens; Joke Salako; Molly Skerker; Charles B Hall; David G Goldfarb; Nadia Jaber; Robert D Daniels; David J Prezant
Journal:  Occup Environ Med       Date:  2021-09-10       Impact factor: 4.948

Review 5.  Thyroid Cancer Diagnostics Related to Occupational and Environmental Risk Factors: An Integrated Risk Assessment Approach.

Authors:  Gabriela Maria Berinde; Andreea Iulia Socaciu; Mihai Adrian Socaciu; Andreea Cozma; Armand Gabriel Rajnoveanu; Gabriel Emil Petre; Doina Piciu
Journal:  Diagnostics (Basel)       Date:  2022-01-27

6.  A comparative analysis of histologic types of thyroid cancer between career firefighters and other occupational groups in Florida.

Authors:  Kemi Ogunsina; Tulay Koru-Sengul; Valentina Rodriguez; Alberto J Caban-Martinez; Natasha Schaefer-Solle; Soyeon Ahn; Erin N Kobetz; Monique N Hernandez; David J Lee
Journal:  BMC Endocr Disord       Date:  2022-09-02       Impact factor: 3.263

7.  Impact of healthcare services on thyroid cancer incidence among World Trade Center-exposed rescue and recovery workers.

Authors:  David G Goldfarb; Hilary L Colbeth; Molly Skerker; Mayris P Webber; David J Prezant; Christopher R Dasaro; Andrew C Todd; Dana Kristjansson; Jiehui Li; Robert M Brackbill; Mark R Farfel; James E Cone; Janette Yung; Amy R Kahn; Baozhen Qiao; Maria J Schymura; Paolo Boffetta; Charles B Hall; Rachel Zeig-Owens
Journal:  Am J Ind Med       Date:  2021-07-18       Impact factor: 3.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.